Labeler · US market

GM Pharmaceuticals, INC

GM Pharmaceuticals, INC is a US drug labeler with US FDA registrations covering 16 drug concepts (16 currently active) across 22 packages. It is currently the only active US supplier of 12 drugs.

ACTIVE — US

openFDA · updated weekly

Labeler codes58809

Active drugs16

Registrations18 active / 18

Packages22

Sole supplier of12 drugs

Portfolio16 drugs · US

Every drug concept this labeler has US registrations for, by package count.

Drug	Type	NDCs	Packages	Status
Antigens All Zones Grasses Trees And Weeds. Baptisia Tinctoria, Echinacea, Hydrastis Canadensis, Myrrha, Nasturtium Aquaticum, Phytolacca Decandra, Urtica Urens solution/ drops	otc	3	6	SUPPLYING
Chlophedianol Hydrochloride, Dexchlorpheniramine Maleate, And Pseudoephedrine Hydrochloride liquid	otc	1	2	SUPPLYING
Chlophedianol Hcl Pyrilamine Maleate liquid	otc	1	1	SUPPLYING
Dextromethorphan Hydrobromide, Guaifenesin, And Phenylephrine Hydrochloride liquid	otc	1	1	SUPPLYING
Allergy Relief tablet	otc	1	1	SUPPLYING
Diaper Rash Cream cream	otc	1	1	SUPPLYING
Piperonyl Butoxide, Pyrethrum gel	otc	1	1	SUPPLYING
Chlophedianol Hcl, Dexchlorpheniramine Maleate solution	otc	1	1	SUPPLYING
Choline Salicylate,guaifenesin liquid	otc	1	1	SUPPLYING
Chlophedianol Hydrochloride, Pyrilamine Maleate liquid	otc	1	1	SUPPLYING
Triprolidine Hydrochloride liquid	otc	1	1	SUPPLYING
Chlophedianol Hcl, Pyrilamine Maleate solution	otc	1	1	SUPPLYING
Choline Salicylate, Dextromethorphan Hydrobromide, Guaifenesin liquid	otc	1	1	SUPPLYING
Dextromethorphan Hbr, Guaifenesin solution	otc	1	1	SUPPLYING
Caffeine, Choline Salicylate liquid	otc	1	1	SUPPLYING
Pyrilamine Maleate liquid	otc	1	1	SUPPLYING

Sole US supplier

Drugs where this labeler is currently the only active US supplier — a single point of failure if it exits.

+2 more

At a glance

TypeLabeler
Labeler codes58809
Filing names1
Drugs (active)16
Drugs (all time)16
US registrations18
Packages22

Watch this company

Alerts for recalls, exits, and new registrations.

Facility locations, FDA inspections, and parent-company mapping are on the roadmap. Name variants reported to FDA under different spellings are merged into this profile; figures cover the entity across all its filing names.